Cargando…
Cui bono? Large-scale evidence on the impact of COVID-19 policy measures on listed firms()
By using a large international firm-level data set this paper aims to make a contribution in better understanding how COVID-19 related stringency and economic support measures actually affected the corporate sector. Our most important findings can be summarized as follows: First, we find robust evid...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Board of Trustees of the University of Illinois. Published by Elsevier Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10122544/ https://www.ncbi.nlm.nih.gov/pubmed/37132001 http://dx.doi.org/10.1016/j.qref.2023.04.002 |
_version_ | 1785029513217835008 |
---|---|
author | Haimann, Michael Kaserer, Christoph Ljubicic, Kristian |
author_facet | Haimann, Michael Kaserer, Christoph Ljubicic, Kristian |
author_sort | Haimann, Michael |
collection | PubMed |
description | By using a large international firm-level data set this paper aims to make a contribution in better understanding how COVID-19 related stringency and economic support measures actually affected the corporate sector. Our most important findings can be summarized as follows: First, we find robust evidence that stringency measures had a statistically and economically significant positive impact on listed firms. Second, with respect to the effects of economic support measures the evidence seems, at best, to be weakly in favor of a positive impact. Third, small and employment intensive companies profited most from economic support measures. Fourth, also highly leveraged or even Zombie firms profited more from these support measures than others. Overall, the results are in line with official policies aimed at sheltering SMEs and human capital intensive firms from the Corona shock waves. However, it also seems that governments unintentionally supported firms in financial difficulties or with non-viable business models already before the pandemic. |
format | Online Article Text |
id | pubmed-10122544 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Board of Trustees of the University of Illinois. Published by Elsevier Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-101225442023-04-24 Cui bono? Large-scale evidence on the impact of COVID-19 policy measures on listed firms() Haimann, Michael Kaserer, Christoph Ljubicic, Kristian Q Rev Econ Finance Article By using a large international firm-level data set this paper aims to make a contribution in better understanding how COVID-19 related stringency and economic support measures actually affected the corporate sector. Our most important findings can be summarized as follows: First, we find robust evidence that stringency measures had a statistically and economically significant positive impact on listed firms. Second, with respect to the effects of economic support measures the evidence seems, at best, to be weakly in favor of a positive impact. Third, small and employment intensive companies profited most from economic support measures. Fourth, also highly leveraged or even Zombie firms profited more from these support measures than others. Overall, the results are in line with official policies aimed at sheltering SMEs and human capital intensive firms from the Corona shock waves. However, it also seems that governments unintentionally supported firms in financial difficulties or with non-viable business models already before the pandemic. Board of Trustees of the University of Illinois. Published by Elsevier Inc. 2023-06 2023-04-22 /pmc/articles/PMC10122544/ /pubmed/37132001 http://dx.doi.org/10.1016/j.qref.2023.04.002 Text en © 2023 Board of Trustees of the University of Illinois. Published by Elsevier Inc. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Article Haimann, Michael Kaserer, Christoph Ljubicic, Kristian Cui bono? Large-scale evidence on the impact of COVID-19 policy measures on listed firms() |
title | Cui bono? Large-scale evidence on the impact of COVID-19 policy measures on listed firms() |
title_full | Cui bono? Large-scale evidence on the impact of COVID-19 policy measures on listed firms() |
title_fullStr | Cui bono? Large-scale evidence on the impact of COVID-19 policy measures on listed firms() |
title_full_unstemmed | Cui bono? Large-scale evidence on the impact of COVID-19 policy measures on listed firms() |
title_short | Cui bono? Large-scale evidence on the impact of COVID-19 policy measures on listed firms() |
title_sort | cui bono? large-scale evidence on the impact of covid-19 policy measures on listed firms() |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10122544/ https://www.ncbi.nlm.nih.gov/pubmed/37132001 http://dx.doi.org/10.1016/j.qref.2023.04.002 |
work_keys_str_mv | AT haimannmichael cuibonolargescaleevidenceontheimpactofcovid19policymeasuresonlistedfirms AT kasererchristoph cuibonolargescaleevidenceontheimpactofcovid19policymeasuresonlistedfirms AT ljubicickristian cuibonolargescaleevidenceontheimpactofcovid19policymeasuresonlistedfirms |